These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4119182)

  • 1. Screening programme for prevention of Down's syndrome.
    Stein Z; Susser M; Guterman AV
    Lancet; 1973 Feb; 1(7798):305-10. PubMed ID: 4119182
    [No Abstract]   [Full Text] [Related]  

  • 2. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevention of Down's syndrome in the south western region of England 1975-1985.
    Wilson N; Bickley D; McDermott A
    West Engl Med J; 1990 Mar; 105(1):15-7. PubMed ID: 2141994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk assessment adjusted for gestational age in maternal serum screening for Down's syndrome.
    Gardosi J; Mongelli M
    BMJ; 1993 Jun; 306(6891):1509-11. PubMed ID: 8518678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a regional screening programme using maternal serum alpha fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland.
    Crossley JA; Aitken DA; Berry E; Connor JM
    J Med Screen; 1994 Jul; 1(3):180-3. PubMed ID: 8790513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
    DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ
    N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost-benefit analysis of prenatal screening for trisomy 21 through analysis of HCG in maternal blood].
    Seror V; Moatti JP; Muller F; Le Galès C; Boué A
    Rev Epidemiol Sante Publique; 1993; 41(1):3-15. PubMed ID: 8465062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum screening for Down's syndrome, open neural tube defects and trisomy 18.
    Akbas SH; Ozben T; Alper O; Ugur A; Yücel G; Lüleci G
    Clin Chem Lab Med; 2001 Jun; 39(6):487-90. PubMed ID: 11506458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of screening for Down's syndrome in a socioeconomically deprived area with a high ethnic population.
    Ford C; Moore AJ; Jordan PA; Bartlett WA; Wyldes MP; Jones AF; MacKenzie WE
    Br J Obstet Gynaecol; 1998 Aug; 105(8):855-9. PubMed ID: 9746377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). The Brighton and Eastbourne Down's Syndrome Screening Group.
    Piggott M; Wilkinson P; Bennett J
    J Med Screen; 1994 Jan; 1(1):45-9. PubMed ID: 8790485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Maternal serum markers of fetal trisomy 21].
    Muller F; Bussières L; Chevallier B
    Presse Med; 1995 Sep; 24(27):1265-9. PubMed ID: 7501610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief reports decline of Down's syndrome after abortion reform in New York State.
    Hansen H
    Am J Ment Defic; 1978 Sep; 83(2):185-8. PubMed ID: 151507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for antenatal detection of Down's syndrome.
    Wyllie JP; Madar RJ; Wright M; Burn J; Wren C
    Arch Dis Child Fetal Neonatal Ed; 1997 Jan; 76(1):F26-30. PubMed ID: 9059182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antenatal diagnosis of Down's syndrome].
    Liu ZJ; Liang DY; Chen M
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):732-4. PubMed ID: 21176551
    [No Abstract]   [Full Text] [Related]  

  • 17. An economic appraisal of alternative pre-natal screening programmes for Down's syndrome.
    Shackley P; McGuire A; Boyd PA; Dennis J; Fitchett M; Kay J; Roche M; Wood P
    J Public Health Med; 1993 Jun; 15(2):175-84. PubMed ID: 7688977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cost-benefit analysis of the prevention of Down's syndrome by means of prenatal diagnosis during early pregnancy].
    Flatz VG
    Fortschr Med; 1978 Jun; 96(24):1255-6, 1295. PubMed ID: 149085
    [No Abstract]   [Full Text] [Related]  

  • 19. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
    Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA
    N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.